New Zealand markets closed
  • NZX 50

    12,066.79
    -73.87 (-0.61%)
     
  • NZD/USD

    0.7345
    -0.0030 (-0.40%)
     
  • NZD/EUR

    0.6049
    +0.0003 (+0.04%)
     
  • ALL ORDS

    7,105.70
    +56.30 (+0.80%)
     
  • ASX 200

    6,834.00
    +56.20 (+0.83%)
     
  • OIL

    62.91
    -0.62 (-0.98%)
     
  • GOLD

    1,755.30
    -20.10 (-1.13%)
     
  • NASDAQ

    12,828.31
    0.00 (0.00%)
     
  • FTSE

    6,651.96
    -7.01 (-0.11%)
     
  • Dow Jones

    31,402.01
    -559.85 (-1.75%)
     
  • DAX

    13,879.33
    -96.67 (-0.69%)
     
  • Hang Seng

    29,091.22
    -982.95 (-3.27%)
     
  • NIKKEI 225

    28,966.01
    -1,202.26 (-3.99%)
     
  • NZD/JPY

    77.8820
    -0.3880 (-0.50%)
     

Antithrombin Market Research Report by Formulation, by Source, by Type, by Route, by Application - Global Forecast to 2025 - Cumulative Impact of COVID-19

ReportLinker
·5-min read

Antithrombin Market Research Report by Formulation (Liquid and Lyophilized), by Source (Goat Milk and Human), by Type, by Route, by Application - Global Forecast to 2025 - Cumulative Impact of COVID-19

New York, Jan. 18, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Antithrombin Market Research Report by Formulation, by Source, by Type, by Route, by Application - Global Forecast to 2025 - Cumulative Impact of COVID-19" - https://www.reportlinker.com/p06007551/?utm_source=GNW

Market Statistics:
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.

1. The Global Antithrombin Market is expected to grow from USD 599.45 Million in 2020 to USD 931.25 Million by the end of 2025.
2. The Global Antithrombin Market is expected to grow from EUR 525.61 Million in 2020 to EUR 816.53 Million by the end of 2025.
3. The Global Antithrombin Market is expected to grow from GBP 467.27 Million in 2020 to GBP 725.90 Million by the end of 2025.
4. The Global Antithrombin Market is expected to grow from JPY 63,977.39 Million in 2020 to JPY 99,388.21 Million by the end of 2025.
5. The Global Antithrombin Market is expected to grow from AUD 870.49 Million in 2020 to AUD 1,352.30 Million by the end of 2025.

Market Segmentation & Coverage:
This research report categorizes the Antithrombin to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Formulation, the Antithrombin Market studied across Liquid and Lyophilized.

Based on Source, the Antithrombin Market studied across Goat Milk and Human.

Based on Type, the Antithrombin Market studied across Anticoagulant, Antiplatelet, and Thrombolytic Drugs.

Based on Route, the Antithrombin Market studied across Oral and Parenteral.

Based on Application, the Antithrombin Market studied across Diagnostics, Research, and Therapeutics.

"The Asia-Pacific is projected to witness the highest growth during the forecast period"

Based on Geography, the Antithrombin Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom. The Americas commanded the largest size in the Antithrombin Market in 2020. On the other hand, the Asia-Pacific is expected to grow at the fastest CAGR during the forecast period.

Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Antithrombin Market including BioPharm Laboratories, CSL Limited, Dem ilac, Inc, Diapharma Group, Inc., European Medicines Agency, Genesis BioPharma, Grifols, Kedrion S.p.A., Lee Biosolutions, Inc, LFB USA, Machaon Diagnostics, Inc., Merck KGaA, Octapharma AG, rEVO Biologics, Inc., Scripps Laboratories, Inc., Shire PLC, SK Plasma, Techne Corporation, and WebMD LLC..

Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.

360iResearch™ FPNV Positioning Matrix:
The 360iResearch™ FPNV Positioning Matrix evaluates and categorizes the vendors in the Antithrombin Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

360iResearch™ Competitive Strategic Window:
The 360iResearch™ Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch™ Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments

The report answers questions such as:
1. What is the market size and forecast of the Global Antithrombin Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Antithrombin Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Antithrombin Market?
4. What is the competitive strategic window for opportunities in the Global Antithrombin Market?
5. What are the technology trends and regulatory frameworks in the Global Antithrombin Market?
6. What are the modes and strategic moves considered suitable for entering the Global Antithrombin Market?
Read the full report: https://www.reportlinker.com/p06007551/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001